<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>241288</rcn>
  <id>101059469</id>
  <acronym>TargetBRCA</acronym>
  <teaser>Breast and ovarian carcinomas are aggressive tumors with few treatment options and high recurrence rates. About half of these tumors shows defects in homologous recombination (HR) repair. Defect in HR (HRD) causes genomic instability and dependence on poly (ADP-ribose)...</teaser>
  <objective>Breast and ovarian carcinomas are aggressive tumors with few treatment options and high recurrence rates. About half of these tumors shows defects in homologous recombination (HR) repair. Defect in HR (HRD) causes genomic instability and dependence on poly (ADP-ribose) polymerase (PARP)-mediated DNA repair. As a result, PARP inhibitors (PARPi) are now widely used for the treatment of these tumors. However, resistance to PARPi is emerging as the major obstacle to clinical effectiveness. Consequently, many patients run out of treatment options and succumb to the disease. This prompts the development of novel therapeutics.
Beyond its well-known functions in regulating metabolic processes, we discovered that enzyme X maintains genomic stability in HRD cells. Enzyme X inhibition kills HRD cells without affecting HR-proficient cell survival pointing to a synthetic lethal interaction between enzyme X and HR genes. Moreover, we showed that enzyme X functions independently of PARP in the survival of HRD cells. As a result, enzyme X inhibition kills naive and PARPi-resistant HRD cells. Thus, targeting this enzyme has the potential to provide a new cure for HRD tumors.
No inhibitors nor patents on enzyme X exist. HRD tumors being a major economic burden worldwide, developing enzyme X inhibitors has high innovation and financial reward potentials. By screening chemical libraries, we identified a top hit inhibitor of enzyme X. Our TargetBRCA project aims at improving potency and specificity of our molecule inhibitor and provides a proof-of-concept on its use as a cure for HRD tumors. TargetBRCA relies on complementary teams of crystallographers, chemists and specialists of HRD tumor biology and associates structure-aided drug design with the use of preclinical in vivo models. Our ultimate goal is to foster the development of a clinical-grade inhibitor to be used for the treatment of HRD tumors either by licensing and co-development partnerships, or by the creation of a start-up.</objective>
  <title>To develop a new targeted therapy for the treatment of naive and PARP inhibitor-resistant BRCA1/2-mutated tumors</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>150000</ecMaxContribution>
  <startDate>2022-08-01</startDate>
  <endDate>2024-01-31</endDate>
  <ecSignatureDate>2022-07-18</ecSignatureDate>
  <duration>18</duration>
  <status>CLOSED</status>
  <identifiers>
    <grantDoi>10.3030/101059469</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2023-01-13 19:02:42</sourceUpdateDate>
  <contentCreationDate>2022-09-15 13:37:19</contentCreationDate>
  <contentUpdateDate>2022-09-15 13:36:59</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:58</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>446844</rcn>
        <id>446844-frontier-research-for-cancer-laying-foundations-for-effective-action</id>
        <title>Frontier research for cancer: Laying foundations for effective action</title>
        <contentUpdateDate>2023-10-24 11:19:03</contentUpdateDate>
        <relations>
          <associations>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447074</rcn>
              <title>Understanding the mysterious cell bodies that help cure leukaemia</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447070</rcn>
              <title>Tracing brain cancer’s ‘cell of origin’ points to pre-birth</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447076</rcn>
              <title>A new hope for treatment-resistant breast and ovarian cancer</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447075</rcn>
              <title>Suppressing cancer from within using microRNA</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447078</rcn>
              <title>Revealing global inequalities in female cancers</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447073</rcn>
              <title>New tools to better understand and fight paediatric sarcomas</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447071</rcn>
              <title>Advancing immunotherapy to solve the colorectal cancer paradox</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447072</rcn>
              <title>Melanoma insights could hold benefit for all cancers</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <article source="editorial" type="contains">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>447077</rcn>
              <title>Delivering chemotherapy with a lighter touch</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/brief</code>
                    <title>Result in Brief</title>
                    <description>Article: Classic and enhanced</description>
                    <displayCode>/Result in Brief</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <webItem type="relatedImage" source="editorial" represents="article">
              <language>any</language>
              <availableLanguages>de,es,fr,it,pl,any</availableLanguages>
              <uri>/docs/article/images/2023-10/446844.jpg</uri>
              <mimetype>image/jpeg</mimetype>
              <size>0</size>
            </webItem>
            <webLink source="editorial" type="formatPdf" represents="article">
              <title>Download PDF version</title>
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>ec8e8514-7c68-11ee-99ba-01aa75ed71a1_pdf</id>
              <physUrl>https://op.europa.eu/o/opportal-service/download-handler?identifier=ec8e8514-7c68-11ee-99ba-01aa75ed71a1&amp;format=PDF&amp;language=en&amp;productionSystem=cellar</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
            <webLink source="editorial" type="orderPrint" represents="postcard">
              <title>Order paper copy</title>
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <id>48eb959e-7c5f-11ee-99ba-01aa75ed71a1_print</id>
              <physUrl>https://op.europa.eu/en/publication-detail/-/publication/48eb959e-7c5f-11ee-99ba-01aa75ed71a1/</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
            <webLink source="editorial" type="formatPdf" represents="postcard">
              <title>Download PDF version</title>
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>48eb959e-7c5f-11ee-99ba-01aa75ed71a1_pdf</id>
              <physUrl>https://op.europa.eu/o/opportal-service/download-handler?identifier=48eb959e-7c5f-11ee-99ba-01aa75ed71a1&amp;format=PDF&amp;language=en&amp;productionSystem=cellar</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
            <webLink source="editorial" type="orderPrint" represents="article">
              <title>Order paper copy</title>
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <id>ec8e8514-7c68-11ee-99ba-01aa75ed71a1_print</id>
              <physUrl>https://op.europa.eu/en/publication-detail/-/publication/ec8e8514-7c68-11ee-99ba-01aa75ed71a1/</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
          </associations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode>/Health</displayCode>
            </category>
            <category classification="audience" type="isTargetedTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/RES</code>
              <title>Research organisation</title>
              <displayCode>/Research organisation</displayCode>
            </category>
            <category classification="client" type="isRequestedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ERCEA.C</code>
              <title>ERCEA - Grant Management Department</title>
              <description>2016</description>
              <displayCode>/ERCEA - Grant Management Department</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/resultsPack</code>
              <title>Results Pack</title>
              <description>Article: Collections of results, from finished or nearly completed projects, focusing on a specific theme that you can apply in your domain</description>
              <displayCode>/Results Pack</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
        <teaser>Cancer represents one of Europe’s most pressing public health concerns. The European Research Council plays a pivotal role in advancing our understanding of cancer development and progression through its support for curiosity-driven research, thereby paving the way for innovative treatments. This Results Pack highlights nine frontier research projects dedicated to advancing cancer research.</teaser>
      </article>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>447076</rcn>
        <id>447076-a-new-hope-for-treatment-resistant-breast-and-ovarian-cancer</id>
        <title>A new hope for treatment-resistant breast and ovarian cancer</title>
        <contentUpdateDate>2023-10-17 08:30:34</contentUpdateDate>
        <relations>
          <associations>
            <article source="editorial" type="isContainedIn">
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <rcn>446844</rcn>
              <title>Frontier research for cancer: Laying foundations for effective action</title>
              <relations>
                <categories>
                  <category classification="applicationDomain" type="isApplicableIn">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/health</code>
                    <title>Health</title>
                    <displayCode>/Health</displayCode>
                  </category>
                  <category classification="audience" type="isTargetedTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/RES</code>
                    <title>Research organisation</title>
                    <displayCode>/Research organisation</displayCode>
                  </category>
                  <category classification="client" type="isRequestedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/ERCEA.C</code>
                    <title>ERCEA - Grant Management Department</title>
                    <description>2016</description>
                    <displayCode>/ERCEA - Grant Management Department</displayCode>
                  </category>
                  <category classification="collection" type="belongsTo">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/resultsPack</code>
                    <title>Results Pack</title>
                    <description>Article: Collections of results, from finished or nearly completed projects, focusing on a specific theme that you can apply in your domain</description>
                    <displayCode>/Results Pack</displayCode>
                  </category>
                  <category classification="source" type="isProvidedBy">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/editorial</code>
                    <title>CORDIS Editorial</title>
                    <description>Written by CORDIS</description>
                    <displayCode>/CORDIS Editorial</displayCode>
                  </category>
                </categories>
              </relations>
            </article>
            <webItem type="relatedImage" source="editorial" represents="article">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl,any</availableLanguages>
              <uri>/docs/article/images/2023-10/447076.jpg</uri>
              <mimetype>image/jpeg</mimetype>
              <size>160585</size>
              <copyright>© Africa Studio/stock.adobe.com</copyright>
            </webItem>
          </associations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode>/Health</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/brief</code>
              <title>Result in Brief</title>
              <description>Article: Classic and enhanced</description>
              <displayCode>/Result in Brief</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
        <teaser>The EU-funded TargetBRCA project has identified new ways to attack tumours that resist conventional treatments such as chemotherapy.</teaser>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55465</rcn>
        <title>ERC-2022-POC1</title>
        <identifier>ERC-2022-POC1</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55465</rcn>
        <title>ERC-2022-POC1</title>
        <identifier>ERC-2022-POC1</identifier>
      </call>
      <organization netEcContribution="150000" totalCost="0" source="corda" order="1" ecContribution="150000" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1908707</rcn>
        <id>999896759</id>
        <vatNumber>FR32784257164</vatNumber>
        <legalName>INSTITUT CURIE</legalName>
        <shortName>INSTITUT CURIE FONDATION</shortName>
        <address>
          <street>RUE D ULM 26</street>
          <city>Paris</city>
          <postalCode>75231</postalCode>
          <country>FR</country>
          <postBox>N/A</postBox>
          <url>http://www.curie.fr</url>
          <geolocation>48.8424525,2.3442707</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Paris</name>
              <rcn>258740225</rcn>
              <nutsCode>FR101</nutsCode>
              <parents>
                <region>
                  <name>Ile-de-France</name>
                  <rcn>258740264</rcn>
                  <nutsCode>FR10</nutsCode>
                  <parents>
                    <region>
                      <name>Ile-de-France</name>
                      <rcn>258742824</rcn>
                      <nutsCode>FR1</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706226</rcn>
        <id>HORIZON_ERC-2022-POC1</id>
        <code>ERC-2022-POC1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC PROOF OF CONCEPT GRANTS1</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1134615</rcn>
        <id>101059469_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - TargetBRCA (To develop a new targeted therapy for the treatment of naive and PARP inhibitor-resistant BRCA1/2-mutated tumors)</title>
        <description>periodic</description>
        <teaser>Among the many molecular mechanisms that lead to cancer development and progression, gain-of-function alterations in oncogenes (genes with potential to contribute to the development of cancer) and loss-of-function mutations in tumor suppressor genes’ (normal genes that slow...</teaser>
        <sourceUpdateDate>2024-06-08 11:34:04</sourceUpdateDate>
        <contentUpdateDate>2024-07-24 11:58:38</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/337/1015</code>
        <title>DNA</title>
        <displayCode>/natural sciences/biological sciences/genetics/DNA</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/315/997/1613/1617</code>
        <title>enzymes</title>
        <displayCode>/natural sciences/biological sciences/biochemistry/biomolecules/proteins/enzymes</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-ERC-POC</code>
        <title>HORIZON ERC Proof of Concept Grants</title>
        <description>HORIZON ERC Proof of Concept Grants</description>
        <displayCode>/HORIZON ERC Proof of Concept Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>